Jorge Lobo's disease is a cutaneous and subcutaneous mycosis that affects patients in the Amazon region. The number of patients is relatively small, but the real situation of the disease as public health problem is not known, because Jorge Lobo's disease is not a notifiable disease. This study aims to report the clinical evolution in patients affected and to determine the prevalence and areas of occurrence of the disease. A retrospective study was carried out based on the analysis of the clinical records, which included a collection of photographs of patients in the Department of Sanitary Dermatology, in Rio Branco, and patients seen in the interior of the state. In a decade, in Rio Branco, 249 cases of the disease were reported, 30 were females and 219 males. Of these patients, 153 had localized lesions, 94 of them were on one ear, 55 had multifocal lesions and 41 had disseminated lesions. The average time between the onset of symptoms and diagnosis was 19 years. The average age at the time of diagnosis was 53 years, and ages ranged from 14 to 96 years.

Download full-text PDF

Source
http://dx.doi.org/10.1590/s0036-46652010000500010DOI Listing

Publication Analysis

Top Keywords

jorge lobo's
12
lobo's disease
12
amazon region
8
rio branco
8
diagnosis years
8
disease
7
patients
6
ten years
4
years experience
4
experience jorge
4

Similar Publications

Importance: Sodium-glucose cotransporter 2 (SGLT-2) inhibitors improve outcomes in patients with type 2 diabetes, heart failure, and chronic kidney disease, but their effect on outcomes of critically ill patients with organ failure is unknown.

Objective: To determine whether the addition of dapagliflozin, an SGLT-2 inhibitor, to standard intensive care unit (ICU) care improves outcomes in a critically ill population with acute organ dysfunction.

Design, Setting, And Participants: Multicenter, randomized, open-label, clinical trial conducted at 22 ICUs in Brazil.

View Article and Find Full Text PDF
Article Synopsis
  • Both Jorge Lobo's disease (JLD) and lepromatous leprosy (LL) have common features such as a weakened cellular immune response, primarily due to macrophage dysfunction, impacting disease maintenance.
  • The study compared macrophage subtypes in skin lesions from JLD patients and LL samples, using specific markers to identify different macrophage responses, revealing no significant density differences in certain markers, but higher resident macrophages in LL.
  • Findings indicate that both diseases have a dominant M2 (anti-inflammatory) response with notable amounts of iNOS+ macrophages, suggesting impaired immune function similar to M2 macrophages that limits effective pathogen eradication.
View Article and Find Full Text PDF

A taxonomic review of the genus Paracoccidioides, with focus on the uncultivable species.

PLoS Negl Trop Dis

April 2023

Microbiology and Molecular Genetics, Biomedical Laboratory Diagnostics, Michigan State University, East Lansing, Michigan, United States of America.

Paracoccidioides species have always been surrounded by taxonomic uncertainties. The continuing nomenclatoral muddle was caused in part by the failure of Adolfo Lutz and Jorge Lôbo to name the etiologic agents of human paracoccidioidomycosis and Jorge Lôbo's diseases, respectively. Early in their history, it was postulated that the cultivable species causing systemic infections belonged in the genus Paracoccidioides, whereas the uncultivable species, causing skin disease, were not part of the genus.

View Article and Find Full Text PDF
Article Synopsis
  • * An immunohistochemical study identified higher levels of vimentin compared to α-smooth muscle actin (α-SMA) across all three conditions, with specific expressions of other markers like CD31, CD34, and p16 differing by disease type.
  • * Vimentin emerges as a key marker for the fibrotic process in these diseases, while TGF-β is predominantly present in keloids and lacaziosis, suggesting potential pathways for targeted interventions.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!